Compare FLL & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | CSBR |
|---|---|---|
| Founded | 1987 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.7M | 82.7M |
| IPO Year | 2014 | 2015 |
| Metric | FLL | CSBR |
|---|---|---|
| Price | $2.57 | $6.20 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 126.1K | 5.9K |
| Earning Date | 03-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.45 | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $302,376,000.00 | $2,900,000.00 |
| Revenue This Year | $8.87 | $4.84 |
| Revenue Next Year | $5.50 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.53 | N/A |
| 52 Week Low | $2.02 | $5.50 |
| 52 Week High | $4.95 | $10.17 |
| Indicator | FLL | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 52.19 | 49.47 |
| Support Level | $2.20 | N/A |
| Resistance Level | $2.96 | $6.24 |
| Average True Range (ATR) | 0.19 | 0.24 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 56.25 | 71.43 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.